These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2563836)

  • 1. Plasma-derived versus recombinant hepatitis B vaccines.
    Kurtz JB; Alder MJ; Mayon-White RT; Juel-Jensen BE; Rodgers TM; Babic GM
    Lancet; 1989 Feb; 1(8635):451. PubMed ID: 2563836
    [No Abstract]   [Full Text] [Related]  

  • 2. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and efficacy of anti-hepatitis B vaccines in hemodialysis patients.
    Dentico P; Volpe A; Buongiorno R; Maracchione N; Carbone M; Manno C; Proscia F
    Nephron; 1992; 61(3):324-5. PubMed ID: 1386904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast recombinant hepatitis B vaccine.
    Hilleman MR
    Infection; 1987; 15(1):3-7. PubMed ID: 2437037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore.
    Guan R; Tay HH; Yap I; Smith R; Tan LH
    Trans R Soc Trop Med Hyg; 1990; 84(5):731-2. PubMed ID: 2148992
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity study of a plasma-derived heat-inactivated hepatitis-B vaccine in newborn babies: a randomised dose-response study.
    Ip HM; Wong VC; Reesink HW; Lelie PN; Yeung CY; Ma HK
    Asia Oceania J Obstet Gynaecol; 1988 Sep; 14(3):367-71. PubMed ID: 2972271
    [No Abstract]   [Full Text] [Related]  

  • 7. Trial of SKF rDNA hepatitis B vaccine.
    Milne A
    N Z Med J; 1989 Apr; 102(866):198-9. PubMed ID: 2523526
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccine choice and program participation rates when two hepatitis B vaccines are offered.
    Harris AA; Daly-Gawenda D; Hudson EK
    J Occup Med; 1991 Jul; 33(7):804-7. PubMed ID: 1832443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
    Schmid K; Strebl H; Heck KJ; Weltle D; Raithel HJ
    Gesundheitswesen; 1992 May; 54(5):219-22. PubMed ID: 1535816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma-derived and yeast-derived hepatitis B vaccines.
    Ellis RW; Gerety RJ
    Am J Infect Control; 1989 Jun; 17(3):181-9. PubMed ID: 2662828
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reactivity and immunogenicity of Engerix B, the recombinant DNA vaccine against hepatitis B].
    Borcić B; Gasparović V; Mihaljevic I; Aleraj B; Margan IG
    Acta Med Iugosl; 1989; 43(4):247-54. PubMed ID: 2534021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of yeast-derived hepatitis B vaccine in Pakistani adults.
    Zuberi SJ; Lodi TZ; Hassan R; Alam SE
    Indian J Gastroenterol; 1990 Oct; 9(4):291-2. PubMed ID: 2258214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a heat-treated recombinant DNA hepatitis B vaccine.
    Just M; Berger R
    Vaccine; 1988 Oct; 6(5):399-400. PubMed ID: 2973693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of hepatitis B vaccine in Chinese school children: a comparison of two plasma-derived vaccines.
    Lee SD; Lo KJ; Tsai YT; Chan CY; Wu TC; Hwang SJ; Chang CP; Huang YS
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Aug; 42(2):87-92. PubMed ID: 3066454
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience with hepatitis B vaccines.
    West DJ
    Am J Infect Control; 1989 Jun; 17(3):172-80. PubMed ID: 2662827
    [No Abstract]   [Full Text] [Related]  

  • 16. [Unsuccessful vaccination against hepatitis B].
    Jilg W
    Dtsch Med Wochenschr; 1990 Nov; 115(46):1773. PubMed ID: 2146107
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis B vaccine: responder status and timing of additional booster doses.
    Fagan EA; Williams R; Eddleston AL
    Lancet; 1987 Sep; 2(8558):561. PubMed ID: 2887842
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness.
    Stephenne J
    Vaccine; 1988 Aug; 6(4):299-303. PubMed ID: 2973187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B--United States, 1990-1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(33):569-72. PubMed ID: 1830921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Active hepatitis B immunization--current status of development and effectiveness].
    Baumgarten R; Fengler JD
    Z Arztl Fortbild (Jena); 1986; 80(10):393-4. PubMed ID: 2944291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.